https://www.selleckchem.com/products/gne-317.html
To analyze the survival of patients hospitalized with COVID-19 and who presented some vascular thrombotic complication. All consecutive patients with COVID-19 who were treated during the months of March and April 2020 at our institution were included. All patients were symptomatic and the thrombotic event objectively confirmed. Patients with deep vein thrombosis (DVT), pulmonary embolism (PE), ischemic stroke, and peripheral arterial thrombosis (PAT) were included. Survival curves for all groups were analyzed using Kaplan-Meier with Log
Aimer
Commentaire
Partagez
